Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARγ

Vascular Pharmacology

Volumn 46, Issue 2, 2007, Pages 114-121

  Ge, Heng ^a   Zhang, Jun feng ^b   Guo, Bing shi ^c   He, Qing ^a   Wang, Bin yao ^a   He, Ben ^a   Wang, Chang qian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

EMMPRIN; Macrophages; MMPs; PPAR ; Resveratrol

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CD147 ANTIGEN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHORBOL 13 ACETATE 12 MYRISTATE; PIOGLITAZONE; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN U937; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; MACROPHAGE MIGRATION INHIBITION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TANDEM REPEAT; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANILIDES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD147; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; PPAR GAMMA; PROMOTER REGIONS (GENETICS); STILBENES; TETRADECANOYLPHORBOL ACETATE; THIAZOLIDINEDIONES; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 33845565752     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.08.412     Document Type: Article

References (40)

1. Belguendouz L., Fremont L., and Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 53 9 (1997) 1347-1355 (May 9)
2. Bordador L.C., Li X., Toole B., et al. Expression of EMMPRIN by oral squamous cell carcinoma. Int. J. Cancer 85 (2000) 347-352
3. Brown D.L., Desai K.K., Vakili B.A., et al. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler. Thromb. Vasc. Biol. 24 4 (2004) 733-738 (Apr)
4. Chase A.J., Bond M., Crook M.F., et al. Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler. Thromb. Vasc. Biol. 22 5 (2002) 765-771 (May 1)
5. Di Santo A., Mezzetti A., Napoleone E., et al. Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells. J. Thromb. Haemost. 1 (2003) 1089-1095
6. Fabunmi R.P., Sukhova G.K., and Sugiyama S. Expression of tissue inhibitor of metalloproteinase-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. Circ. Res. 83 3 (1998) 270-278 (Aug 10)
7. Galis Z.S., Muszynski M., Sukhova G.K., et al. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann. N. Y. Acad. Sci. 748 (1995) 501-507 (Jan 17)
8. Hagemann T., Wilson J., Kulbe H., et al. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J. Immunol. 175 2 (2005) 1197-1205 (Jul 15)
9. Ikeda U., and Shimada K. Matrix metalloproteinases and coronary artery diseases. Clin. Cardiol. 26 2 (2003) 55-59 (Feb)
10. Inoue H., Jiang X.F., Katayama T., et al. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci. Lett 352 3 (2003) 203-206 (Dec 11)
11. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
12. Jiang X., Zeng H.S., and Guo Y. The expression of matrix metalloproteinase-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability. Chin. Med. J. (Engl) 117 12 (2004) 1825-1829 (Dec)
13. Kataoka H., DeCastro R., Zucker S., et al. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase stromelysin, and 72-kDa gelatinase. Cancer Res. 53 (1993) 3154-3158
14. Langcake P., and Pryce R. The production of resveratrol by Vitis vinfera and other members of the Vitaceae as a response to infection or injury. Physiol. Plant Pathol. 9 (1976) 77-86
15. Leiro J., Alvarez E., Arranz J.A., et al. Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J. Leukoc. Biol. 75 6 (2004) 1156-1165 (Jun)
16. Li Z., Li L., Zielke H.R., et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am. J. Pathol. 148 1 (1996) 121-128 (Jan)
17. Li Y.T., Shen F., Bai J.Y., et al. Inhibition of dexamethasone, indomethacin and resveratrol on matrix metalloproteinase-9 and the mechanism of inhibition. Yao Xue Xue Bao 38 (2003) 501-504
18. Lim M., Martinez T., Jablons D., et al. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett. 441 (1998) 88-92
19. Lu Y., and Wahl L.M. Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway. J. Leukoc. Biol. 78 1 (2005) 259-265 (Jul)
20. Luttun A., Lutgens E., Manderveld A., et al. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 109 11 (2004) 1408-1414 (Mar 23)
21. Major T.C., Liang L., Lu X., et al. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler. Thromb. Vasc. Biol. 22 7 (2002) 1200-1207 (Jul)
22. Marx N., Sukhova G., and Murphy C. Macrophages in human atheroma contain PPAR gamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPAR gamma) expression and reduction of MMP-9 activity through PPAR gamma activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153 (1998) 17-23
23. Miyauchi T., Kanekura T., Yamaoka A., et al. Basigin, a new, broadly distributed member of the immunoglobulin superfamily, has strong homology with both the immunoglobulin V domain and the β-chain of major histocompatibility complex class II antigen. J. Biochem. 107 (1990) 316-323
24. Nareika A., He L., Game B.A., et al. Sodium lactate increases LPS-stimulated MMP and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-kappaB transcriptional activities. Am. J. Physiol: Endocrinol. Metab. 289 4 (2005) E534-E542 (Oct)
25. Ogawa K., Chen F., Kuang C., et al. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem. J. 381 pt2 (2004) 413-422
26. Pasceri V., Wu H.D., Willerson J.T., et al. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator activated receptor-gamma activators. Circulation 101 (2000) 235-238
27. Pasterkamp G., Schoneveld A.H., Hijnen D.J., et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150 2 (2000) 245-253 (Jun)
28. Polette M., Gilles C., Marchand V., et al. Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J. Histochem. Cytochem. 45 (1997) 703-709
29. Sameshima T., Nabeshima K., Toole B.P., et al. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in cocultures with brain-derived fibroblasts. Cancer Lett. 157 (2000) 177-184
30. Shah P.K., Falk E., Badimon J.J., et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92 6 (1995) 1565-1569 (Sep 15)
31. Shin J., Edelberg J.E., and Hong M.K. Vulnerable atherosclerotic plaque: clinical implications. Curr. Vasc. Pharmacol. 1 2 (2003) 183-204 (Jun)
32. Si A.I., Huang L., Xu J., et al. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone. J. Cell. Biochem. 89 6 (2003) 1154-1163 (Aug 15)
33. Siemann E.H., and Creasy L.L. Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 43 (1992) 49-52
34. Staels B. PPARgamma and atherosclerosis. Curr. Med. Res. Opin. 21 Suppl 1 (2005) S13-S20
35. Staffler G., and Stockinger H. EMMPRIN. J. Biol. Regul. Homeost. Agents 14 (2000) 327-330
36. Uzui H., Harpf A., Liu M., et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 106 24 (2002) 3024-3030 (Dec 10)
37. van Bilsen M., van der Vusse G.J., and Gilde A.J. Peroxisome proliferator-activated receptors: lipid binding proteins controlling gene expression. Mol. Cell. Biochem. 239 1-2 (2002) 131-138 (Oct)
38. Yoo H.G., Shin B.A., Park J.S., et al. IL-1beta induces MMP-9 via reactive oxygen species and NF-kappaB in murine macrophage RAW 264.7 cells. Biochem. Biophys. Res. Commun. 298 2 (2002) 251-256 (Oct 25)
39. Yoon Y.W., Kwon H.M., Hwang K.C., et al. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque. Atherosclerosis 180 1 (2005) 37-44 (May)
40. Zeng B., Prasan A., Fung K.C., et al. Elevated circulating levels of matrix metalloproteinase-9 and-2 in patients with symptomatic coronary artery disease. Intern. Med. J. 35 6 (2005) 331-335 (Jun)